查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1594358

口腔炎治疗药物市场：按药物类别、配方和最终用户划分 - 全球预测 2025-2030

Mouth Ulcers Treatment Market by Drug Class (Analgesics, Antihistamine, Antimicrobial), Formulation (Gels & Ointments, Mouthwash, Sprays), End-User - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 193 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

口腔炎治疗药物市场2023年估值为12.3亿美元，预计到2024年将达到13亿美元，复合年增长率为5.26%，预计到2030年将达到17.7亿美元。

口腔溃疡治疗市场包括旨在减轻口腔溃疡（口疮性溃疡）症状和促进癒合的产品和治疗方法，口腔溃疡是一种在口腔中发生的疼痛性溃疡。这些治疗的需求源于口腔溃疡的流行，由于压力、营养缺乏和某些健康状况等因素，口腔溃疡影响了很大一部分人口。口腔溃疡的治疗用途包括非处方凝胶、乳霜、清洗和处方药，目的是即时缓解症状并促进癒合。最终使用领域包括医院、牙科诊所和居家照护场所，反映了从专业牙科治疗到自我护理解决方案的广泛消费群体。推动市场成长要素包括口腔健康意识的提高、药物配方的进步以及对即时缓解解决方案不断增长的需求。天然和草本治疗方法的开发蕴藏着新的商机，反映出消费者对有机产品日益增长的偏好。此外，都市化进程的加速和生活方式的改变正在推动人们对预防性医疗保健的关注，为企业提供创新预防性医疗保健解决方案的机会。然而，市场成长受到对产品功效的担忧、潜在副作用和新兴市场定价压力等因素的阻碍。此外，发展中地区认知度低也是阻碍因素。在应用奈米技术进行药物持续释放和使用生物技术进行标靶治疗都有创新。将人工智慧更好地融入预测建模和个人化治疗计划的研究代表了业务成长的前沿。专注于最大限度地减少副作用和最大限度地提高药物传输有效性的研究将改善治疗结果。随着现有製药公司和新参与企业寻求生物友好且具有成本效益的解决方案，市场竞争仍在继续，需要建立策略联盟来维持市场地位并利用新机会和持续创新的重要性。

主要市场统计
基准年[2023] 12.3亿美元
预测年份 [2024] 13亿美元
预测年份 [2030] 17.7亿美元
复合年增长率（%） 5.26%

市场动态：快速发展的口腔炎治疗市场的关键市场洞察

供需的动态交互作用正在改变口腔溃疡药物市场。透过了解这些不断变化的市场动态，公司可以准备好做出明智的投资决策、完善策略决策并抓住新的商机。全面了解这些趋势可以帮助企业降低政治、地理、技术、社会和经济领域的风险，并了解消费行为及其对製造成本的影响，并更清楚地了解对采购趋势的影响。

  • 市场驱动因素
    • 世界人口中口腔炎的盛行率很高
    • 用于治疗口腔溃疡的商业产品的可用性
    • 越来越重视以病人为中心的口腔溃疡治疗计划
  • 市场限制因素
    • 现有口腔炎治疗方法效果有限
  • 市场机会
    • 介绍一种新的、更有效的口腔溃疡治疗方法
    • 医疗保健支出不断增加，人们更加关注口腔健康
  • 市场挑战
    • 与口腔溃疡相关的某些副作用

波特五力：驾驭口腔炎药物市场的策略工具

波特的五力框架是理解市场竞争格局的重要工具。波特的五力框架为评估公司的竞争地位和探索策略机会提供了清晰的方法。该框架可帮助公司评估市场动态并确定新业务的盈利。这些见解使公司能够利用自己的优势，解决弱点并避免潜在的挑战，从而确保更强大的市场地位。

PESTLE分析：了解口腔炎治疗药物市场的外部影响

外部宏观环境因素在塑造口腔炎治疗药物市场的表现动态中起着至关重要的作用。对政治、经济、社会、技术、法律和环境因素的分析提供了应对这些影响所需的资讯。透过调查 PESTLE 因素，公司可以更了解潜在的风险和机会。这种分析可以帮助公司预测法规、消费者偏好和经济趋势的变化，并帮助他们做出积极主动的决策。

市场占有率分析 了解口腔炎治疗药物市场的竞争状况

口腔炎治疗药物市场的详细市场占有率分析可以对供应商的表现进行全面评估。公司可以透过比较收益、客户群和成长率等关键指标来揭示自己的竞争定位。该分析揭示了市场集中、分散和整合的趋势，为供应商提供了製定策略决策所需的洞察力，使他们能够在日益激烈的竞争中占有一席之地。

FPNV定位基质口腔炎治疗市场供应商表现评估

FPNV定位矩阵是评估口腔炎治疗市场供应商的重要工具。此矩阵允许业务组织根据供应商的商务策略和产品满意度评估供应商，从而做出符合其目标的明智决策。这四个象限使您能够清晰、准确地划分供应商，并确定最能满足您的策略目标的合作伙伴和解决方案。

策略分析与建议，描绘口腔炎治疗市场的成功之路

对于旨在加强其在全球市场的影响力的公司来说，口腔炎治疗药物市场的策略分析至关重要。透过审查关键资源、能力和绩效指标，公司可以识别成长机会并努力改进。这种方法使您能够克服竞争环境中的挑战，利用新的商机，并取得长期成功。

本报告对市场进行了全面分析，涵盖关键重点领域：

1. 市场渗透率：对当前市场环境的详细审查、主要企业的广泛资料、对其在市场中的影响力和整体影响力的评估。

2. 市场开拓：辨识新兴市场的成长机会，评估现有领域的扩张潜力，并提供未来成长的策略蓝图。

3. 市场多元化：分析近期产品发布、开拓地区、关键产业进展、塑造市场的策略投资。

4. 竞争评估与情报：彻底分析竞争格局，检验市场占有率、业务策略、产品系列、认证、监理核准、专利趋势、主要企业的技术进步等。

5. 产品开发与创新：重点在于有望推动未来市场成长的最尖端科技、研发活动和产品创新。

我们也回答重要问题，帮助相关人员做出明智的决策：

1.目前的市场规模和未来的成长预测是多少？

2. 哪些产品、区隔市场和地区提供最佳投资机会？

3.塑造市场的主要技术趋势和监管影响是什么？

4.主要厂商的市场占有率和竞争地位如何？

5. 推动供应商市场进入和退出策略的收益来源和策略机会是什么？

目录

第一章 前言

第二章调查方法

第三章执行摘要

第四章市场概况

第五章市场洞察

  • 市场动态
    • 促进因素
      • 世界人口中口腔溃疡的盛行率很高
      • 治疗口腔炎的非处方药的可用性
      • 口腔炎治疗计划增加了以病人为中心的护理的重要性
    • 抑制因素
      • 现有的口腔炎治疗方法效果有限
    • 机会
      • 介绍一种新的、更有效的口腔溃疡治疗方法
      • 医疗保健成本不断上升，人们对口腔健康的兴趣日益浓厚
    • 任务
      • 与口腔溃疡相关的某些副作用
  • 市场区隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 经济
    • 社群
    • 技术的
    • 合法地
    • 环境

第六章依药物类别分類的口腔炎治疗药物市场

  • 止痛药
  • 抗组织胺药
  • 抗菌的
  • 皮质类固醇

第七章 处方口腔炎治疗药物市场

  • 凝胶和软膏
  • 漱口水
  • 喷

第八章口腔炎治疗药物市场：依最终使用者分类

  • 牙医诊所
  • 医院

第九章北美及南美口腔炎治疗药物市场

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美国

第十章亚太口腔炎治疗药物市场

  • 澳洲
  • 中国
  • 印度
  • 印尼
  • 日本
  • 马来西亚
  • 菲律宾
  • 新加坡
  • 韩国
  • 台湾
  • 泰国
  • 越南

第十一章 欧洲、中东和非洲口腔炎治疗药物市场

  • 丹麦
  • 埃及
  • 芬兰
  • 法国
  • 德国
  • 以色列
  • 义大利
  • 荷兰
  • 奈及利亚
  • 挪威
  • 波兰
  • 卡达
  • 俄罗斯
  • 沙乌地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公国
  • 英国

第十二章竞争格局

  • 2023 年市场占有率分析
  • FPNV 定位矩阵，2023
  • 竞争情境分析
  • 战略分析和建议

公司名单

  • 3M Company
  • Apotex Inc.
  • Blairex Laboratories Inc
  • Blistex Inc.
  • Bristol-Myers Squibb Company
  • Church & Dwight, Inc.
  • Colgate-Palmolive Company
  • Dr. Reddy's Laboratories Ltd
  • EPIEN Medical Inc.
  • GlaxoSmithKline PLC
  • Guilin Sanjin Pharmaceutical Co Ltd
  • ICPA Health Products Ltd.
  • Intas Pharmaceuticals Ltd.
  • LloydsPharmacy Limited
  • Meta Tubex Private Limited
  • Patterson Dental Supply, Inc.
  • Pfizer Inc.
  • Prince Care Pharma Private Limited
  • Raptakos Brett & Company Limited
  • Reckitt Benckiser Group PLC
  • Sinclair Pharma Ltd.
  • STADA Arzneimittel AG
  • Sun Pharmaceutical Industries Ltd
  • Sunstar Suisse SA
  • Taro Pharmaceutical Industries Ltd.
Product Code: MRR-2A0283E25685

The Mouth Ulcers Treatment Market was valued at USD 1.23 billion in 2023, expected to reach USD 1.30 billion in 2024, and is projected to grow at a CAGR of 5.26%, to USD 1.77 billion by 2030.

The scope of the mouth ulcers treatment market encompasses the products and therapies aimed at alleviating the symptoms and promoting healing of mouth ulcers, or aphthous ulcers, which are painful sores that occur in the oral cavity. The necessity for these treatments arises from the prevalence of mouth ulcers, which affect a significant portion of the population due to causes like stress, nutritional deficiencies, and certain health conditions. Applications of mouth ulcer treatments include over-the-counter gels, creams, rinses, and prescribed medications, targeting immediate relief and accelerated healing. End-use segments involve hospitals, dental clinics, and home care settings, reflecting a broad consumer base from professional dental care to self-care solutions. Key growth factors driving the market include increasing awareness about oral health, advancements in pharmaceutical formulations, and the rising demand for quick-relief solutions. Emerging opportunities lie in the development of natural or herbal-based treatments, reflecting growing consumer preference for organic products. Furthermore, increasing urbanization and lifestyle changes are encouraging preventive care focus, presenting opportunities for companies to innovate preventive care solutions. However, market growth is challenged by factors like product efficacy concerns, potential side effects, and pricing pressures in emerging markets. Additionally, the lack of awareness in developing regions acts as a constraint. Innovations are seen in nanotechnology applications for sustained drug release and the use of biotechnology for targeted therapies. Greater integration of artificial intelligence in research for predictive modeling and personalized treatment plans represents a frontier for business growth. Research focused on minimizing side-effects and maximizing drug delivery efficacy is poised to improve treatment outcomes. The market remains competitive with established pharmaceutical companies and new entrants exploring bio-friendly and cost-effective solutions, emphasizing the importance of strategic alliances and continuous innovation to maintain market presence and leverage new opportunities.

KEY MARKET STATISTICS
Base Year [2023] USD 1.23 billion
Estimated Year [2024] USD 1.30 billion
Forecast Year [2030] USD 1.77 billion
CAGR (%) 5.26%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Mouth Ulcers Treatment Market

The Mouth Ulcers Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • High prevalence of mouth ulcers among global population
    • Availability of over-the-counter products for mouth ulcer treatment
    • Growing emphasis on patient-centric care mouth ulcer treatment plans
  • Market Restraints
    • Limited efficacy of existing treatments for mouth ulcers
  • Market Opportunities
    • Introduction of new and more effective mouth ulcer treatments
    • Rising healthcare expenditure and increased focus on oral health
  • Market Challenges
    • Certain side effects associated with mouth ulcers

Porter's Five Forces: A Strategic Tool for Navigating the Mouth Ulcers Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Mouth Ulcers Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Mouth Ulcers Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Mouth Ulcers Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Mouth Ulcers Treatment Market

A detailed market share analysis in the Mouth Ulcers Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Mouth Ulcers Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Mouth Ulcers Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Mouth Ulcers Treatment Market

A strategic analysis of the Mouth Ulcers Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Mouth Ulcers Treatment Market, highlighting leading vendors and their innovative profiles. These include 3M Company, Apotex Inc., Blairex Laboratories Inc, Blistex Inc., Bristol-Myers Squibb Company, Church & Dwight, Inc., Colgate- Palmolive Company, Dr. Reddy's Laboratories Ltd, EPIEN Medical Inc., GlaxoSmithKline PLC, Guilin Sanjin Pharmaceutical Co Ltd, ICPA Health Products Ltd., Intas Pharmaceuticals Ltd., LloydsPharmacy Limited, Meta Tubex Private Limited, Patterson Dental Supply, Inc., Pfizer Inc., Prince Care Pharma Private Limited, Raptakos Brett & Company Limited, Reckitt Benckiser Group PLC, Sinclair Pharma Ltd., STADA Arzneimittel AG, Sun Pharmaceutical Industries Ltd, Sunstar Suisse S.A, and Taro Pharmaceutical Industries Ltd..

Market Segmentation & Coverage

This research report categorizes the Mouth Ulcers Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Drug Class, market is studied across Analgesics, Antihistamine, Antimicrobial, and Corticosteroids.
  • Based on Formulation, market is studied across Gels & Ointments, Mouthwash, and Sprays.
  • Based on End-User, market is studied across Dental Clinics and Hospitals.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. High prevalence of mouth ulcers among global population
      • 5.1.1.2. Availability of over-the-counter products for mouth ulcer treatment
      • 5.1.1.3. Growing emphasis on patient-centric care mouth ulcer treatment plans
    • 5.1.2. Restraints
      • 5.1.2.1. Limited efficacy of existing treatments for mouth ulcers
    • 5.1.3. Opportunities
      • 5.1.3.1. Introduction of new and more effective mouth ulcer treatments
      • 5.1.3.2. Rising healthcare expenditure and increased focus on oral health
    • 5.1.4. Challenges
      • 5.1.4.1. Certain side effects associated with mouth ulcers
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Mouth Ulcers Treatment Market, by Drug Class

  • 6.1. Introduction
  • 6.2. Analgesics
  • 6.3. Antihistamine
  • 6.4. Antimicrobial
  • 6.5. Corticosteroids

7. Mouth Ulcers Treatment Market, by Formulation

  • 7.1. Introduction
  • 7.2. Gels & Ointments
  • 7.3. Mouthwash
  • 7.4. Sprays

8. Mouth Ulcers Treatment Market, by End-User

  • 8.1. Introduction
  • 8.2. Dental Clinics
  • 8.3. Hospitals

9. Americas Mouth Ulcers Treatment Market

  • 9.1. Introduction
  • 9.2. Argentina
  • 9.3. Brazil
  • 9.4. Canada
  • 9.5. Mexico
  • 9.6. United States

10. Asia-Pacific Mouth Ulcers Treatment Market

  • 10.1. Introduction
  • 10.2. Australia
  • 10.3. China
  • 10.4. India
  • 10.5. Indonesia
  • 10.6. Japan
  • 10.7. Malaysia
  • 10.8. Philippines
  • 10.9. Singapore
  • 10.10. South Korea
  • 10.11. Taiwan
  • 10.12. Thailand
  • 10.13. Vietnam

11. Europe, Middle East & Africa Mouth Ulcers Treatment Market

  • 11.1. Introduction
  • 11.2. Denmark
  • 11.3. Egypt
  • 11.4. Finland
  • 11.5. France
  • 11.6. Germany
  • 11.7. Israel
  • 11.8. Italy
  • 11.9. Netherlands
  • 11.10. Nigeria
  • 11.11. Norway
  • 11.12. Poland
  • 11.13. Qatar
  • 11.14. Russia
  • 11.15. Saudi Arabia
  • 11.16. South Africa
  • 11.17. Spain
  • 11.18. Sweden
  • 11.19. Switzerland
  • 11.20. Turkey
  • 11.21. United Arab Emirates
  • 11.22. United Kingdom

12. Competitive Landscape

  • 12.1. Market Share Analysis, 2023
  • 12.2. FPNV Positioning Matrix, 2023
  • 12.3. Competitive Scenario Analysis
  • 12.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. 3M Company
  • 2. Apotex Inc.
  • 3. Blairex Laboratories Inc
  • 4. Blistex Inc.
  • 5. Bristol-Myers Squibb Company
  • 6. Church & Dwight, Inc.
  • 7. Colgate- Palmolive Company
  • 8. Dr. Reddy's Laboratories Ltd
  • 9. EPIEN Medical Inc.
  • 10. GlaxoSmithKline PLC
  • 11. Guilin Sanjin Pharmaceutical Co Ltd
  • 12. ICPA Health Products Ltd.
  • 13. Intas Pharmaceuticals Ltd.
  • 14. LloydsPharmacy Limited
  • 15. Meta Tubex Private Limited
  • 16. Patterson Dental Supply, Inc.
  • 17. Pfizer Inc.
  • 18. Prince Care Pharma Private Limited
  • 19. Raptakos Brett & Company Limited
  • 20. Reckitt Benckiser Group PLC
  • 21. Sinclair Pharma Ltd.
  • 22. STADA Arzneimittel AG
  • 23. Sun Pharmaceutical Industries Ltd
  • 24. Sunstar Suisse S.A
  • 25. Taro Pharmaceutical Industries Ltd.

LIST OF FIGURES

  • FIGURE 1. MOUTH ULCERS TREATMENT MARKET RESEARCH PROCESS
  • FIGURE 2. MOUTH ULCERS TREATMENT MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 13. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 15. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 17. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 21. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. MOUTH ULCERS TREATMENT MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. MOUTH ULCERS TREATMENT MARKET DYNAMICS
  • TABLE 7. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANALGESICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIHISTAMINE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY ANTIMICROBIAL, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY CORTICOSTEROIDS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY GELS & OINTMENTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY MOUTHWASH, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY SPRAYS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY DENTAL CLINICS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL MOUTH ULCERS TREATMENT MARKET SIZE, BY HOSPITALS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 20. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 21. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 22. AMERICAS MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 23. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 24. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 25. ARGENTINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 26. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 27. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 28. BRAZIL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 29. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 30. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 31. CANADA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 32. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 33. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 34. MEXICO MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 35. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 36. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 37. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 38. UNITED STATES MOUTH ULCERS TREATMENT MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 39. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 40. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 41. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 42. ASIA-PACIFIC MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 43. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 44. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 45. AUSTRALIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 46. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 47. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 48. CHINA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 49. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 50. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 51. INDIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 52. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 53. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 54. INDONESIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 55. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 56. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 57. JAPAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 58. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 59. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 60. MALAYSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 61. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 62. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 63. PHILIPPINES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 64. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 65. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 66. SINGAPORE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 67. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 68. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 69. SOUTH KOREA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 70. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 71. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 72. TAIWAN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 73. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 74. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 75. THAILAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 76. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 77. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 78. VIETNAM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 79. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 80. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 81. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 82. EUROPE, MIDDLE EAST & AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 83. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 84. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 85. DENMARK MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 86. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 87. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 88. EGYPT MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 89. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 90. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 91. FINLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 92. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 93. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 94. FRANCE MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 95. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 96. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 97. GERMANY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 98. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 99. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 100. ISRAEL MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 101. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 102. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 103. ITALY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 104. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 105. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 106. NETHERLANDS MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 107. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 108. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 109. NIGERIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 110. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 111. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 112. NORWAY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 113. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 114. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 115. POLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 116. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 117. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 118. QATAR MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 119. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 120. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 121. RUSSIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 122. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 123. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 124. SAUDI ARABIA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 125. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 126. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 127. SOUTH AFRICA MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 128. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 129. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 130. SPAIN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 131. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 132. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 133. SWEDEN MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 134. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 135. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 136. SWITZERLAND MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 137. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 138. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 139. TURKEY MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 140. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 141. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 142. UNITED ARAB EMIRATES MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 143. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY DRUG CLASS, 2018-2030 (USD MILLION)
  • TABLE 144. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY FORMULATION, 2018-2030 (USD MILLION)
  • TABLE 145. UNITED KINGDOM MOUTH ULCERS TREATMENT MARKET SIZE, BY END-USER, 2018-2030 (USD MILLION)
  • TABLE 146. MOUTH ULCERS TREATMENT MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 147. MOUTH ULCERS TREATMENT MARKET, FPNV POSITIONING MATRIX, 2023